Lung (non-small cell) cancer Cancer Lung cancer
Conditions
Interventions
1. Schedule A: Combination chemotherapy, four, 3 weekly cycles of mitomycin, ifosfamide and cisplatin (MIC). Radiotherapy may be given to patients whose symptoms are not responding to the systemic the
Sponsors
Cancer Research UK (CRUK) (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age 75 years or under 2. Histologically or cytologically proven non-small cell lung cancer, ie adeno-squamous or large cell carcinoma 3. Clinically or radiologically evaluable disease 4. Inoperable, but clinically limited stage disease 5. World Health Organisation (WHO) performance status of 0-2 6. No previous chemotherapy or radiotherapy 7. No cerebral metastases, spinal cord compression or symptomatic superior vena cava obstruction 8. Normal renal function 9. No other previous or concurrent malignancy, except cone biopsied carcinoma in-situ of the cervix and adequately treated basal cell carcinoma of the skin 10. No indication that protocol treatment would exacerbate a serious pre-existing medical condition
Exclusion criteria
Exclusion criteria: Not provided at time of registration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed